New hope to relieve dryness and fatigue in Sjögren’s disease Novartis’ iscalimab may improve troubling symptoms in patients with Sjögren’s disease, though there may be safety concerns to address.

https://www.drugdiscoverynews.com/new-hope-to-relieve-dryness-and-fatigue-in-sj-gren-s-disease-16161?utm_campaign=DDN_Newsletter_Dose&utm_medium=email&_hsenc=p2ANqtz-9mq-YmmsYOixuNoZsXR_fqn_q7uGhu--_xbdArSpbp8ThLiJeDKRcjbBK3oKWr6sE-rZ-zELJBrIruyR6VGTSajJIxCA&_hsmi=348091523&utm_content=348091523&utm_source=hs_email